No­var­tis fol­lows up on big CAR-T win by nam­ing Vas Narasimhan as its new CEO

No­var­tis, one of the world’s biggest spenders on drug R&D, will soon be run by a de­vel­op­ment ex­pert.

The phar­ma gi­ant an­nounced Mon­day morn­ing that Joe Jimenez is step­ping down in Feb­ru­ary and hand­ing the reins over to 41-year-old Vas Narasimhan, an ex­u­ber­ant ad­vo­cate of cut­ting-edge sci­ence who’s been mak­ing his mark with a slate of suc­cess­ful pro­grams for the com­pa­ny’s next wave of block­buster drugs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER